Preeclampsia, pregnancy-related hypertension, and breast cancer risk

American Journal of Epidemiology

Volumn 165, Issue 9, 2007, Pages 1007-1014

  Terry, Mary Beth ^a   Perrin, Mary ^a   Salafia, Carolyn M ^a   Zhang, Fang Fang ^a   Neugut, Alfred I ^a   Teitelbaum, Susan L ^b   Britton, Julie ^b   Gammon, Marilie D ^c  

^a Department of Medicine   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c University of North Carolina at Chapel Hill   (United States)

Author keywords

Breast neoplasms; Hypertension, pregnancy induced; Pre eclampsia; Pregnancy

Indexed keywords

CANCER; HEALTH RISK; HYPERTENSION; PREGNANCY; RISK FACTOR; WOMENS HEALTH;

ADULT; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; FEMALE; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARITY; POPULATION RESEARCH; POSTMENOPAUSE; PREECLAMPSIA; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STATISTICAL SIGNIFICANCE;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MIDDLE AGED; NEW YORK; POSTMENOPAUSE; PRE-ECLAMPSIA; PREGNANCY; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TOXEMIA;

LONG ISLAND [NEW YORK]; NEW YORK [UNITED STATES]; NORTH AMERICA; UNITED STATES;

EID: 34247172002     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwk105     Document Type: Article

References (27)

1. Sibai BM. Hypertension. In: Gabbe SG, Niebyl JR, Simpson JL, eds. Obstetrics: normal and problem pregnancies. New York, NY: Churchill Livingstone, 2002:947-52.
2. Roberts JM. Pregnancy-related hypertension. In: Creasy RK, Resnick R, eds. Maternal-fetal medicine. 4th ed. Philadelphia, PA: W B Saunders Company, 1999:835-8.
3. Innes KE, Byers TE. Preeclampsia and breast cancer risk. Epidemiology 1999;10:722-32.
4. Klopper A. Assessment of fetoplacental function by hormone assay. Am J Obstet Gynecol 1970;107:807-27.
5. Isouard G. Measurement of serum levels of oestriol and human placental lactogen in the management of pre-eclamptic pregnancies. Med J Aus 1979;2:401-4.
6. Halhali A, Tovar AR, Torres N, et al. Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments. J Clin Endocrinol Metab 2000;85:1828-33.
7. Ingec M, Gursoy HG, Yildiz L, et al. Serum levels of insulin, IGF-1, and IGFBP-1 in pre-eclampsia and eclampsia. Int J Gynaecol Obstet 2004;84:214-19.
8. Altinkaynak K, Aksoy HH, Bakan E, et al. Serum IGF-I and IGFBP-3 in healthy pregnancies and patients with preeclampsia. Clin Biochem 2003;36:221-3.
9. Polednak AP, Janerich DT. Characteristics of first pregnancy in relation to early breast cancer. A case-control study. J Reprod Med 1983;28:314-18.
10. Thompson WD, Jacobson HI, Negrini B, et al. Hypertension, pregnancy, and risk of breast cancer. J Natl Cancer Inst 1989;81:1571-4.
11. Troisi R, Weiss HA, Hoover RN, et al. Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 1998;9:641-7.
12. Vatten LJ, Romundstad PR, Trichopoulos D, et al. Preeclampsia in pregnancy and subsequent risk for breast cancer. Br J Cancer 2002;87:971-3.
13. Innes KE, Byers TE. First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer 2004;112:306-11.
14. Mogren I, Stenlund H, Hogberg U. Long-term impact of reproductive factors on the risk of cervical, endometrial, ovarian, and breast cancer. Acta Oncol 2001;40:849-54.
15. Paltiel O, Friedlander Y, Tiram E, et al. Cancer after preeclampsia: follow up of the Jerusalem perinatal study cohort. BMJ 2004;328:919-21.
16. Gammon MD, Neugut AI, Santella RM, et al. The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat 2002;74:235-54.
17. Daniel WW. Biostatistics: a foundation for analysis in the health sciences. New York, NY: John Wiley & Sons, Inc, 1991.
18. Hosmer DW, Lemeshow S. Applied logistic regression. New York, NY: John Wiley & Sons, Inc, 1989.
19. Acromite MT, Mantzoros CS, Leach RE, et al. Androgens in preeclampsia. Am J Obstet Gynecol 1999;180:60-3.
20. Troisi R, Potischman N, Roberts JM, et al. Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies. Int J Epidemiol 2003;32:455-60.
21. Audibert F, Benchimol Y, Benattar C, et al. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry. Fetal Diagn Ther 2005;20:48-53.
22. Davidson EJ, Riley SC, Roberts SA, et al. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia. BJOG 2003;110:46-52.
23. Richardson BE, Hulka BS, Peck JL, et al. Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk. Am J Epidemiol 1998;148:719-27.
24. Miller NR, Garry D, Cohen HW, et al. Serum androgen markers in preeclampsia. J Reprod Med 2003;48:225-9.
25. Raty R, Koskinen P, Alanen A, et al. Prediction of preeclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels. Prenat Diagn 1999;19:122-7.
26. Hubinette A, Lichtenstein P, Brismar K, et al. Serum insulin-like growth factors in normal pregnancy and in pregnancies complicated by preeclampsia. Acta Obstet Gynecol Scand 2003;82:1004-9.
27. Rothman KJ, Greenland S. Precision and validity of studies. In: Modern epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers, 1998:115-34.